Cancer patients face significant cancer-related financial burden, reveals study
A new nationwide analysis of more than 1,000 people living with metastatic breast cancer from 41 states reveals significant cancer-related financial burden known as “financial toxicity,” particularly for uninsured patients. Compared to insured respondents, uninsured respondents more often reported refusing or delaying treatment due to cost (96% vs. 36%) and more often reported that they were contacted by a collections agency (92% vs. 30%). They also reported not being able
To continue reading this article
Continue reading your article with a eMediNexus account.